Dual checkpoint blockade of CD47 and PD-L1 using a novel affinity-tuned bispecific antibody maximizes anti-tumor immunity
Ontology highlight
ABSTRACT: Dual checkpoint blockade of CD47 and PD-L1 using a novel affinity-tuned bispecific antibody maximizes anti-tumor immunity
PROVIDER: PRJNA747707 | ENA |
REPOSITORIES: ENA
ACCESS DATA